Success Metrics

Clinical Success Rate
66.7%

Based on 6 completed trials

Completion Rate
67%(6/9)
Active Trials
23(50%)
Results Posted
50%(3 trials)
Terminated
3(7%)

Phase Distribution

Ph phase_3
4
9%
Ph not_applicable
13
28%
Ph phase_2
11
24%

Phase Distribution

0

Early Stage

11

Mid Stage

4

Late Stage

Phase Distribution28 total trials
Phase 2Efficacy & side effects
11(39.3%)
Phase 3Large-scale testing
4(14.3%)
N/ANon-phased studies
13(46.4%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

60.0%

6 of 10 finished

Non-Completion Rate

40.0%

4 ended early

Currently Active

23

trials recruiting

Total Trials

46

all time

Status Distribution
Active(30)
Completed(6)
Terminated(4)
Other(6)

Detailed Status

Recruiting17
Not yet recruiting7
Completed6
Active, not recruiting6
unknown6
Terminated3

Development Timeline

Analytics

Development Status

Total Trials
46
Active
23
Success Rate
66.7%
Most Advanced
Phase 3

Trials by Phase

Phase 211 (39.3%)
Phase 34 (14.3%)
N/A13 (46.4%)

Trials by Status

not_yet_recruiting715%
completed613%
withdrawn12%
active_not_recruiting613%
terminated37%
unknown613%
recruiting1737%

Recent Activity

Clinical Trials (46)

Showing 20 of 46 trialsScroll for more
NCT02609685Not Applicable

Active Surveillance of Papillary Thyroid Microcarcinoma

Recruiting
NCT03803553Phase 3

Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer

Recruiting
NCT07547163

Patient Voice in the Treatment of Low-grade Gliomas: Use of Patient-reported Outcomes, Vorasidenib and Radiotherapy Compared

Recruiting
NCT06358469Not Applicable

STRatIfication of Vulvar SCC by HPV and p53 Status to Guide Excision

Recruiting
NCT05345847Not Applicable

Steroid Sparing in Immune Related Hepatitis (irH)

Recruiting
NCT05343936

Evaluation of an Active Surveillance Protocol for Prostate Cancer in the Brazilian Population

Active Not Recruiting
NCT05840484

Comprehensive Monitoring of Men With Prostate Cancer Cared for by "Active Surveillance

Recruiting
NCT05810467

The Active Surveillance Study

Recruiting
NCT02914873Not Applicable

SPCG17: Prostate Cancer Active Surveillance Trigger Trial

Active Not Recruiting
NCT07262138

Active Surveillance in Older Women With ER+ Breast Cancer

Recruiting
NCT06537154Phase 2

NEO-BLAST: Neoadjuvant Therapy for Bladder Cancer Followed by Active Surveillance vs Treatment

Recruiting
NCT04558593

Surveillance of Complex Renal Cysts - The SOCRATIC Study

Recruiting
NCT07023432Phase 2

Belzutifan's Role in Active Surveillance Versus Treatment for Indolentmetastatic Clear Cell Renal Ccell Carcinoma (BRAVE-RCC)

Not Yet Recruiting
NCT06998342Phase 2

MOHs Surgery and Short-Course Radiation Therapy With Structured Follow-Up for Head & Neck Squamous Cell Skin Cancer

Not Yet Recruiting
NCT06974370Phase 2

Avoiding Radiation Therapy Due to Intracranial Response to Chemotherapy, Targeted Therapy and/or Immuno-ONcology Therapy for Brain Metastases: Pilot Pragmatic Trial

Not Yet Recruiting
NCT06861894Phase 2

Active Surveillance After Neoadjuvant Adebrelimab Combined With Chemoradiotherapy for Resectable ESCC

Not Yet Recruiting
NCT00949819

Active Surveillance for Cancer of the Prostate (ASCaP)

Recruiting
NCT05523856

New Treatment Modalities for Localized Prostate Cancer

Active Not Recruiting
NCT06394037

Active Surveillance for Limited GGNs

Not Yet Recruiting
NCT02799745Phase 2

A Randomized Study of Enzalutamide in Patients With Localized Prostate Cancer Undergoing Active Surveillance

Completed

Drug Details

Intervention Type
OTHER
Total Trials
46